News about Industrial talks

Alkem Reports Record FY26 EBITDA as Revenue Grows 13.5%; Q4 Profit Before Tax Rises 40.7 Percent

Alkem Laboratories posted its highest-ever EBITDA in FY26, driven by strong growth in domestic and international businesses, improved operating leverage, and disciplined cost management. The company also reported robust fourth-quarter performance, with revenue rising 14.6 percent and PBT before exceptional items increasing 40.7 percent YoY.

Industrial talks | 29/05/2026 | By News Bureau

Consultative Meeting on WHO-ICHI Framework and Traditional Medicine Health Codes Concludes

India’s Ministry of Ayush held a two-day consultative meeting on the World Health Organization (WHO)-ICHI framework and National Health Intervention Codes to advance standardised coding systems for Ayurveda, Siddha, and Unani practices under global traditional medicine classification initiatives.

Industrial talks | 28/05/2026 | By News Bureau

PCIM&H Concludes 5-Day Training Program for ASU&H Drug Regulators and Stakeholders

The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) concluded a 5-day capacity building program for ASU&H drug regulators and stakeholders, aimed at strengthening regulatory knowledge, quality standards, and technical competencies across ASU&H sector.

Industrial talks | 25/05/2026 | By News Bureau

Mabylon Advances Peanut Allergy Drug MY006 After Positive Early Clinical Data

Mabylon AG has reported positive preliminary Phase Ia results for MY006, its antibody-based peanut allergy treatment candidate, while also advancing a second allergy programme targeting tree pollen allergens.

Industrial talks | 20/05/2026 | By News Bureau |  158

IPC Hosts Scientific Conclave and Interactive Session on Indian Pharmacopoeia 2026 at NIPER Hyderabad

Indian Pharmacopoeia Commission (IPC) hosts the Indian Pharmacopoeia (IP) 2026 Scientific Conclave and Interactive Session, focusing on medicine quality, impurity standards, regulatory science, and patient safety.

Industrial talks | 16/05/2026 | By News Bureau

Avid Bioservices Names Kerri McCullough Wood Chief Commercial Officer

Avid Bioservices appoints Kerri McCullough Wood as Chief Commercial Officer (CCO) to lead global commercial strategy and accelerate growth across early- and late-phase biologics programs.

Industrial talks | 12/05/2026 | By News Bureau

NIPER Raebareli Signs CDA and Tech Transfer Pact with Lofty Laboratories

NIPER Raebareli signs CDA and technology transfer agreement with Lofty Laboratories to advance indigenous technology commercialisation in biotechnology sector.

Industrial talks | 11/05/2026 | By News Bureau

Viatris Appoints Paul Campbell as Interim Chief Financial Officer

Viatris announces Chief Financial Officer (CFO) transition as Theodora “Doretta” Mistras departs and Paul Campbell is named interim CFO, ensuring leadership continuity.

Industrial talks | 05/05/2026 | By News Bureau

Addex Therapeutics Reports Promising Preclinical Results for Novel Chronic Cough Therapy

Addex Therapeutics’ experimental GABAB modulator shows potential as a well-tolerated, long-term treatment option for chronic cough, addressing a significant unmet need in idiopathic pulmonary fibrosis patients.

Industrial talks | 04/05/2026 | By News Bureau

European Medicines Agency Launches Advisory Group to Tackle Vaccine Hesitancy

‘European Medicines’ Advisory Group aims to rebuild public trust, strengthen vaccine communication and counter misinformation across Europe.

Industrial talks | 02/05/2026 | By News Bureau